BioCanvas
표적 · TPPP3

TPPP3 항체

2최다 인용
25인용된 항체
12벤더
Antibody Registry데이터 출처 · RRID CC0

논문 인용순 항체

Antibody Registry 인용수 기준 · 25종
1
Abcam#ab150998 RRID:AB_2716739 polyclonal
2
cited by
2
MyBioSource#MBS8245680 RRID:AB_2801645 polyclonal
1
cited by
3
Proteintech#15057-1-AP RRID:AB_2878105 polyclonal
1
cited by
4
Abnova#H00051673-B02P RRID:AB_1707196 polyclonal
0
cited by
5
Aviva Systems Biology#ARP42458_P050 RRID:AB_2046859 polyclonal
0
cited by
6
US Biological#B2704-25 RRID:AB_2206050 monoclonal
0
cited by
7
Novus#H00051673-B02P RRID:AB_2206051 polyclonal
0
cited by
9
Creative Diagnostics#DCABH-201641 RRID:AB_2495041 monoclonal
0
cited by
10
Creative Diagnostics#DPABH-03153 RRID:AB_2508391 unknown
0
cited by
11
Thermo Fisher Scientific#PA5-24925 RRID:AB_2542425 polyclonal
0
cited by
12
Thermo Fisher Scientific#PA5-61560 RRID:AB_2648854 polyclonal
0
cited by
13
Atlas Antibodies#HPA047629 RRID:AB_2680108 polyclonal
0
cited by
14
Thermo Fisher Scientific#PA5-69178 RRID:AB_2689046 polyclonal
0
cited by
15
ABclonal#A6775 RRID:AB_2767358 polyclonal
0
cited by
16
Thermo Fisher Scientific#PA5-93213 RRID:AB_2806672 polyclonal
0
cited by
17
Novus#NBP2-13469 (also NBP2-13469-25ul) RRID:AB_3261127 polyclonal
0
cited by
18
Novus#NBP2-95209 (also NBP2-95209-0.02ml, NBP2-95209-0.1ml) RRID:AB_3464949 polyclonal
0
cited by
19
Novus#NBP3-00282 (also NBP3-00282-100ul, NBP3-00282-50ul) RRID:AB_3530010 polyclonal
0
cited by
20
Novus#NBP3-00282AF350 RRID:AB_3530011 polyclonal
0
cited by
21
Novus#NBP3-00282AF405 RRID:AB_3530012 polyclonal
0
cited by
22
Novus#NBP3-00282AF488 RRID:AB_3530013 polyclonal
0
cited by
23
Novus#NBP3-00282AF532 RRID:AB_3530014 polyclonal
0
cited by
24
Novus#NBP3-00282AF594 RRID:AB_3530015 polyclonal
0
cited by
25
Novus#NBP3-00282AF647 RRID:AB_3530016 polyclonal
0
cited by
이 표적 항체를 국내 공급가·납기로 확인하시겠어요? 국내 구매·견적 문의 →

TPPP3

이 표적에 논문에서 가장 많이 인용된 항체 순으로 정리했습니다. 각 행에서 국내 견적을 요청할 수 있습니다.

Data: Antibody Registry (SciCrunch) — RRID under CC-0; product metadata per respective source. Citation counts: Antibody Registry.